Fatal pneumonitis after treatment with pegylated liposomal doxorubicin in a patient with metastatic breast cancer in complete remission

Med Oncol. 2012 Sep;29(3):1477-8. doi: 10.1007/s12032-011-0002-1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Breast Neoplasms / complications
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives*
  • Fatal Outcome
  • Female
  • Humans
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / mortality
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / pathology
  • Pleural Effusion, Malignant / drug therapy
  • Pleural Effusion, Malignant / etiology
  • Polyethylene Glycols / adverse effects*
  • Remission Induction

Substances

  • Antineoplastic Agents
  • liposomal doxorubicin
  • Polyethylene Glycols
  • Doxorubicin